Details for New Drug Application (NDA): 065414
✉ Email this page to a colleague
The generic ingredient in CEFOXITIN is cefoxitin sodium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for 065414
Tradename: | CEFOXITIN |
Applicant: | Acs Dobfar |
Ingredient: | cefoxitin sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065414
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065414 | ANDA | Sagent Pharmaceuticals | 25021-109 | 25021-109-10 | 10 VIAL in 1 CARTON (25021-109-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065414 | ANDA | Sagent Pharmaceuticals | 25021-110 | 25021-110-20 | 10 VIAL in 1 CARTON (25021-110-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Jun 12, 2009 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Jun 12, 2009 | TE: | AP | RLD: | No |
Complete Access Available with Subscription